Roche to reintroduce ocular implant two years after pulling it off the market

Roche plans to reintroduce Susvimo, its ocular implant pulled almost two years ago for manufacturing issues, in the coming weeks.

In late 2022, the company’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

CDC advises healthcare providers on new tools to combat RSV

The CDC predicts increased activity of Respiratory Syncytial Virus (RSV) for the upcoming winter season, urging clinicians to implement new prevention tools like nirsevimab and

September 11, 2023

DOUGLAS continues sales and profit growth in third quarter – Biotech Investments

EQS-News: Douglas GmbH / Key word(s): 9 Month figures Douglas GmbH: DOUGLAS continues sales and profit growth in third quarter 24.08.2023 / 07:30 CET/CEST The

August 25, 2023

Opinion | ‘May Be Better at Evading Prior Immunity’: What We Heard This Week

“It may be better at evading prior immunity, both from vaccination and infection.” — Aubree Gordon, PhD, MPH, of the University of Michigan in Ann

August 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.